Clinical Trials Arena November 7, 2022
William Newton

Blockchain has been billed as a transformative technology that could improve drug traceability in clinical trial supply chains, but many industry experts are skeptical.

Blockchain technology, which safely and securely records valuable data, has emerged as a solution for transparently tracking complex supply chains. However, many experts are doubtful that pharma—generally a conservative and tightly regulated industry—will implement or benefit from this technology.

Experts say the pharma industry has a low appetite for investment in blockchain, particularly given the more promising supply chain tracking alternatives, such as radio frequency identification (RFID). Meanwhile, pharma supply chains are already tightly regulated, so the industry cannot benefit from blockchain the way other industries might.

“Blockchain is a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Blockchain, Clinical Trials, Supply Chain, Trends
Blockaid Raises $50 Million to Scale Support for Blockchain Security Platform
The Trump admin will encourage—not hinder—U.S. leadership in blockchain technology and cryptocurrency. We must seize the moment
Blockchain-Proven Content And Nvidia Alternative? Check Out CrowdGenAI
How New Tech Changes Blockchain: Web3 Trends 2025
Musk Reportedly Weighs Blockchain to Track Federal Spending

Share This Article